Dermatology Times, March 2021 (Vol. 42, No. 3)

2021’s Top Challenges Facing Physicians

March 23, 2021

In late 2020, our sister publication, Medical Economics®, conducted a Physicians Report asking physician audiences what they thought would be the most challenging issues they will face this year. Here is what the respondents said.

Systemic Therapy Advances for AD

March 10, 2021

The limited armamentarium of systemic therapies for atopic dermatitis has already been expanded with the approval of dupilumab. Forthcoming systemic therapies are expected to include a new biologic and three new Janus kinase (JAK) inhibitors.

The Potential of Precision Medicine

March 05, 2021

Taking the polar opposite of a one-size-fits-all approach, clinicians now factor in a patient’s genetic profile, medical history, microbiome composition, lifestyle, and diet, among other parameters, otherwise known as precision medicine.